Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
United Healthcare Medical Policy Updates – March 2019
Click here to view the United Healthcare Medical Policy Updates »
March 2019 Medical Policy Updates:
- 17-Alpha-Hydroxyprogesterone Caproate (Makena™ and 17P)
- Actemra ®(Tocilizumab) Injection for Intravenous Infusion
- Alpha1-Proteinase Inhibitors
- Benlysta ®(Belimumab)
- Botulinum Toxins A and
- Breast Imaging for Screening and Diagnosing Cancer
- Brineura™ (Cerliponase Alfa)
- Buprenorphine (Probuphine ®& Sublocade™)
- Chelation Therapy for Non-Overload Conditions
- Clotting Factors and Coagulant Blood Products
- Cognitive Rehabilitation
- Crysvita (Burosumab-Twza)
- Denosumab (Prolia ®& Xgeva®)
- Elbow Replacement Surgery (Arthroplasty)
- Emergency Health Care Services and Urgent Care Center Services
- Entyvio ®(Vedolizumab)
- Enzyme Replacement Therapy
- Erythropoiesis-Stimulating Agents
- Exondys 51 ™(Eteplirsen)
- Fetal Aneuploidy Testing Using Cell-Free Fetal Nucleic Acids in Maternal Blood
- Gamifant™ (Emapalumab-Lzsg)
- Gonadotropin Releasing Hormone Analogs
- Habilitative Services and Outpatient Rehabilitation Therapy
- Hereditary Angioedema (HAE), Treatment and Prophylaxis
- Home Hemodialysis
- Ilaris ®(Canakinumab)
- Ilumya™ (Tildrakizumab-Asmn)
- Immune Globulin (IVIG and SCIG)
- Immune Globulin Site of Care Review Guidelines for Medical Necessity of Hospital Outpatient Facility Infusion
- Infliximab (Remicade®, Inflectra™, Renflexis™)
- Inpatient Pediatric Feeding Programs
- Intravenous Enzyme Replacement Therapy (ERT) for Gaucher Disease
- Ketamine
- Lemtrada (Alemtuzumab)
- Luxturna™ (Voretigene Neparvovec-Rzyl)
- Maximum Dosage
- Meniscus Implant and Allograft
- Mifeprex (Mifepristone)
- Neuropsychological Testing Under the Medical Benefit
- New Version of the Knowledge Library (KL) Released
- Obstructive Sleep Apnea Treatment
- Ocrevus™ (Ocrelizumab)
- Off-Label/Unproven Specialty Drug Treatment
- Oncology Medication Clinical Coverage
- Onpatrro (Patisiran)
- Ophthalmologic Policy: Vascular Endothelial Growth Factor (VEGF) Inhibitors
- Orencia ®(Abatacept) Injection for Intravenous Infusion
- Outpatient Cardiac Telemetry
- Parsabiv™ (Etelcalcetide)
- Platelet Derived Growth Factors for Treatment of Wounds
- Propranolol Treatment for Infantile Hemangiomas: Inpatient Protocol
- Radicava™ (Edaravone)
- Repository Corticotropin Injection
- Respiratory Interleukins (Cinqair®, Fasenra®, and Nucala )®
- Review at Launch for New to Market Medications
- Rituxan ®(Rituximab)
- Self-Administered Medications
- Shoulder Replacement Surgery (Arthroplasty)
- Simponi Aria ®(Golimumab) Injection for Intravenous Infusion
- Soliris (eculizumab), Ultomiris (ravulizumab-cwvz)
- Soliris ®(Eculizumab)
- Somatostatin Analogs
- Specialty Medication Administration – Site of Care Review Guidelines
- Spinraza ™(Nusinersen)
- Stelara ®(Ustekinumab)
- Subcutaneous Implantable Hormone Pellets
- Subcutaneous Implantable Naltrexone Pellets
- Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins
- Surgical Treatment for Spine Pain
- Synagis ®(Palivizumab)
- Temporomandibular Joint Disorders
- Total Artificial Disc Replacement for the Spine
- Trogarzo™ (Ibalizumab-Uiyk)
- Vaccines
- White Blood Cell Colony Stimulating Factors
- Xolair ®(Omalizumab)
Click here to view the United Healthcare Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
